| Drug Type Small molecule drug | 
| Synonyms LUF 5826, LUF5826 | 
| Target | 
| Action antagonists | 
| Mechanism A1R antagonists(Adenosine A1 receptor antagonists) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingPreclinical | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC16H12F2N4O2S | 
| InChIKeyFBSFJYUGTIAIKV-UHFFFAOYSA-N | 
| CAS Registry791619-95-9 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Nervous System Diseases | Preclinical | United States  | 24 Mar 2005 | 





